Cargando…

Healthcare Resource Use and Costs Associated with Opioid Initiation Among Patients with Newly Diagnosed Endometriosis with Commercial Insurance in the USA

INTRODUCTION: To compare all-cause and endometriosis-related healthcare resource utilization (HCRU) and healthcare costs by service categories (outpatient, inpatient, emergency room [ER], pharmacy) among patients with newly diagnosed endometriosis using opioids compared to patients with endometriosi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Estes, Stephanie J., Soliman, Ahmed M., Zivkovic, Marko, Chopra, Divyan, Zhu, Xuelian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467429/ https://www.ncbi.nlm.nih.gov/pubmed/32399813 http://dx.doi.org/10.1007/s12325-020-01361-7

Ejemplares similares

The impact of high-risk and chronic opioid use among commercially insured endometriosis patients on health care resource utilization and costs in the United States
por: Estes, Stephanie J, et al.
Publicado: (2020)

Economic Burden and Healthcare Resource Use of Alopecia Areata in an Insured Population in the USA
por: Mostaghimi, Arash, et al.
Publicado: (2022)

Treatment Patterns of Newly Diagnosed Rheumatoid Arthritis Patients from a Commercially Insured Population
por: Kern, David M., et al.
Publicado: (2018)

Impact of Endometriosis Diagnostic Delays on Healthcare Resource Utilization and Costs
por: Surrey, Eric, et al.
Publicado: (2020)

Changes in Healthcare Resource Use and Costs in Commercially Insured Insomnia Patients Initiating Suvorexant
por: Kale, Hrishikesh P., et al.
Publicado: (2021)

Real-world treatment modalities, health care resource utilization, and costs among commercially insured patients with newly diagnosed major depressive disorder in the United States
por: Pizzicato, Lia N, et al.
Publicado: (2023)

Health Care Resource Utilization in Management of Opioid-Naive Patients With Newly Diagnosed Neck Pain
por: Jin, Michael C., et al.
Publicado: (2022)

Comprehensive healthcare resource use among newly diagnosed congestive heart failure
por: Bash, Lori D., et al.
Publicado: (2017)

Economic Evaluation of Healthcare Resource Utilization and Costs for Newly Diagnosed Dementia-Related Psychosis
por: Rashid, Nazia, et al.
Publicado: (2022)

Naloxone Prescriptions Among Commercially Insured Individuals at High Risk of Opioid Overdose
por: Follman, Sarah, et al.
Publicado: (2019)

Endometriosis and Opioid Receptors: Are Opioids a Possible/Promising Treatment for Endometriosis?
por: Guan, Qihui, et al.
Publicado: (2023)

Healthcare resource availability and cardiovascular health in the USA
por: Pilkerton, Courtney S, et al.
Publicado: (2017)

Pricing in commercial dental insurance and provider markets
por: Nasseh, Kamyar, et al.
Publicado: (2020)

Burden of Endometriosis: Infertility, Comorbidities, and Healthcare Resource Utilization
por: Eisenberg, Vered H., et al.
Publicado: (2022)

Healthcare use in commercially insured youth with mental health disorders
por: Hugunin, Julie, et al.
Publicado: (2022)

Healthcare Resources Utilization and Costs of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease Based on Insurance Claims in the USA
por: Olson, Amy L., et al.
Publicado: (2020)

Incidence of Treatment for Opioid Use Disorder Following Nonfatal Overdose in Commercially Insured Patients
por: Kilaru, Austin S., et al.
Publicado: (2020)

A retrospective analysis to estimate the healthcare resource utilization and cost associated with treatment-resistant depression in commercially insured US patients
por: Li, Gang, et al.
Publicado: (2020)

Healthcare resource utilization and costs before and after long-acting injectable antipsychotic initiation in commercially insured young adults with schizophrenia
por: Fu, Alex Z., et al.
Publicado: (2022)

Healthcare Costs of Clostridioides difficile Infection in Commercially Insured Younger Adults
por: Sahrmann, John M, et al.
Publicado: (2023)

Impact of prenatal substance use policies on commercially insured pregnant females with opioid use disorder
por: Tabatabaeepour, Nadia, et al.
Publicado: (2022)

Utilization, Timing, and Outcomes of BRCA Genetic Testing Among Women With Newly Diagnosed Breast Cancer From a National Commercially Insured Population: The ABOARD Study
por: Armstrong, Joanne, et al.
Publicado: (2021)

Treatment patterns, adverse events, healthcare resource use and costs among commercially insured patients with mantle cell lymphoma in the United States
por: Kabadi, Shaum M., et al.
Publicado: (2019)

Healthcare Resource Use and Costs Associated with Organ Damage in Newly Diagnosed Adults with Systemic Lupus Erythematosus in the UK
por: Stirnadel-Farrant, Heide A., et al.
Publicado: (2023)

Healthcare Utilization and Cost Burden of Porphyria in Commercially Insured Adults in the United States
por: Elsaid, Mohamed I., et al.
Publicado: (2020)

Healthcare costs and utilization for privately insured patients treated for non-infectious uveitis in the USA
por: Chu, David S, et al.
Publicado: (2013)

Trends in opioid use in commercially insured and Medicare Advantage populations in 2007-16: retrospective cohort study
por: Jeffery, Molly Moore, et al.
Publicado: (2018)

Geographic Variation in the Use of Gabapentinoids and Opioids for Pain in a Commercially Insured Adult Population in the United States
por: Zhao, Danni, et al.
Publicado: (2022)

Chronic pain diagnoses and opioid dispensings among insured individuals with serious mental illness
por: Owen-Smith, Ashli, et al.
Publicado: (2020)

Healthcare Resource Utilization and Costs Among Commercially Insured Patients With Advanced or Recurrent Endometrial Cancer Initiating First-Line Therapy in the United States
por: Kobayashi, Monica, et al.
Publicado: (2023)

EE391 Impact of the COVID-19 Pandemic on the Healthcare Resource Use of People With Newly Diagnosed Mood/Affective Disorder
por: Junker, S, et al.
Publicado: (2022)

Healthcare Resource Utilization in Patients with Newly Diagnosed Atrial Fibrillation: A Global Analysis from the GARFIELD-AF Registry
por: Mantovani, Lorenzo G., et al.
Publicado: (2023)

Analysis of a Commercial Insurance Policy to Deny Coverage for Emergency Department Visits With Nonemergent Diagnoses
por: Chou, Shih-Chuan, et al.
Publicado: (2018)

Dose patterns in commercially insured subjects chronically exposed to opioids: a large cohort study in the United States
por: Cepeda, Maria Soledad, et al.
Publicado: (2010)

The challenge of healthcare big data to China’s commercial health insurance industry: evaluation and recommendations
por: Wu, Jun, et al.
Publicado: (2022)

Endometriosis Knowledgebase: a gene-based resource on endometriosis
por: Joseph, Shaini, et al.
Publicado: (2019)

Obesity and healthcare resource utilization: comparative results from the UK and the USA
por: Nørtoft, E., et al.
Publicado: (2017)

Opioid utilization among pediatric patients treated for newly diagnosed acute myeloid leukemia
por: Getz, Kelly D., et al.
Publicado: (2018)

Increased Healthcare Resource Use and Costs After Discontinuation of Liraglutide in Patients with Type 2 Diabetes from a Commercial- and Medicaid-Insured Claims Database
por: Uzoigwe, Chioma, et al.
Publicado: (2022)

A Longitudinal Assessment of the Impact of Endometriosis on Patients’ Salary Growth and Risk of Leaving the Workforce
por: Estes, Stephanie J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9tu2ngrknm6hsesksh0stha1m3